CareDx, Inc.

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

• PAPeter AltmanDirector
• GBGeorge BickerstaffDirector
• GBG. Steven BurrillDirector
• BBBrook ByersDirector
• PCPierre CassigneulDirector · Executive Officer
• FCFred CohenDirector
• CCCharles ConstantiExecutive Officer
• MGMichael GoldbergDirector
• WHWilliam HagstromDirector
• AKAnders KarlssonExecutive Officer
• VLVijay LathiDirector
• DLDavid LevisonDirector
• PMPeter MaagDirector · Executive Officer
• MMMatthew MyerExecutive Officer
• MNMitchell NellesExecutive Officer
• JSJohn SninskyExecutive Officer
• RSRalph SnydermanDirector
• JVJean ViretExecutive Officer
• TWTodd WhitsonExecutive Officer
• JYJames YeeExecutive Officer

• 03 Sept 2026Systems And Methods For Distinguishing Nucleic Acids In Mixed Samplesapplication
• 01 Sept 2026Methods And Systems For Monitoring A Recipient Of An Allograftgranted
• 27 Aug 2026Methods And Systems For Monitoring A Recipient Of An Allograftapplication
• 02 Jun 2026Methods And Systems For Monitoring A Recipient Of An Allograftgranted
• 14 May 2026Methods And Systems For Monitoring A Recipient Of An Allograftapplication
• 25 Dec 2025Methods for monitoring allogeneic cellsapplication
• 16 Oct 2025Systems And Methods For Distinguishing Nucleic Acids In Mixed Samplesapplication
• 09 Oct 2025Sequence-based Analysis Of Nucleic Acids In Mixed Samplesapplication
• 02 Sept 2025Methods And Systems For Monitoring A Recipient Of An Allograftgranted
• 26 Jun 2025Apparatuses, Computer-implemented Methods, And Systems For Generating And Dynamically Updating A Metric Progress Aggregation Insight Interface In Association With A Pre- Or Post-transplant Recipientapplication
• 09 Jan 2025Methods For Non-invasively Monitoring Organ Health In Cross-species Transplantationapplication
• 21 Dec 2023Methods Of Monitoring Immunosuppressive Therapies In A Transplant Recipientapplication

• 07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
• 30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
• 30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
• 29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
• 26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
• 26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.